The differentiation between intracranial atherosclerotic stenosis (ICAS) and intracranial embolism as the immediate cause of acute ischemic stroke requiring endovascular therapy is important but challenging. In cases of ICAS, we often observe a phenomenon we call the microcatheter "first-pass effect, " which is temporary blood flow through the occluded intracranial artery when the angiographic microcatheter is initially advanced through the site of total occlusion and immediately retrieved proximally. OBJECTIVE: To evaluate whether this microcatheter first-pass effect can be used to differentiate ICAS from intracranial embolism. METHODS: A total of 61 patients with acute ischemic stroke resulting from large intracranial artery occlusion and in whom recanalization was achieved by endovascular treatment were included in the study. The microcatheter first-pass effect was tested in these patients. The sensitivity, specificity, positive predictive values (PPV), and accuracy of the microcatheter first-pass effect for prediction of ICAS were assessed. RESULTS: The microcatheter first-pass effect was more frequently observed in patients with ICAS than in those with intracranial embolism (90.9% vs 12.8%, P < .001). For identifying ICAS, sensitivity, specificity, PPV, and accuracy of the microcatheter first-pass effect were 90.9%, 87.2%, 80.0%, 88.5%, respectively. CONCLUSION: The sensitivity and PPV of the microcatheter first-pass effect are high for prediction of ICAS in patients with acute symptoms.
I
ntracranial atherosclerosis is common in Asia, and it accounts for 25% to 50% of ischemic strokes. 1, 2 The reported incidence of acute occlusion resulting from intracranial atherosclerotic stenosis (ICAS) is 22.9% in Asia 3 and 5.5% in western countries. 4 Mechanical thrombectomy is an effective treatment for acute ABBREVIATIONS: ACG, American Society of Interventional and Therapeutic Neuroradiology collateral grading scale; BA, basilar artery; CTA, computed tomography angiography; HAS, hyperdense artery sign; ICA, internal carotid artery; ICAS, Intracranial atherosclerotic stenosis; MCA, middle cerebral artery; MR, magnetic resonance; MRA, magnetic resonance angiography; mRS, modified Rankin Scale; NIHSS, NIH Stroke Scale; NPV, negative predictive value; PPV, positive predictive value; TICI, thrombolysis in cerebral infarction ischemic stroke caused by intracranial artery occlusion, [5] [6] [7] [8] [9] [10] but it was designed primarily for embolic occlusion rather than ICAS. 11 Although mechanical thrombectomy results in reperfusion, reocclusion often occurs at the site of the ICAS due to subsequent platelet aggregation. 12, 13 Thus, rescue therapy such as emergency angioplasty or stenting 3, 13, 14 is often required. For these reasons, it is very important to differentiate ICAS from intracranial embolism.
ICAS can be detected and evaluated by means of high-resolution vessel wall magnetic resonance (MR) imaging. [15] [16] [17] [18] [19] However, such imaging must be performed on a 3.0T or 7.0T MR scanner, neither of which is housed by most municipal hospitals. In addition, the MR studies are time-consuming and require the patient's cooperation. Being able to differentiate ICAS from intracranial embolism during endovascular NEUROSURGERY VOLUME 0 | NUMBER 0 | 2018 | 1 Downloaded from https://academic.oup.com/neurosurgery/advance-article-abstract/doi/10.1093/neuros/nyy183/5001323 by University of Winnipeg user on 24 May 2018 intervention would be a practical and time-saving solution to the problem.
Endovascular intervention has become standard treatment for acute occlusion of a large intracranial artery, with more and more patients receiving such therapy. We have observed, especially in cases of ICAS, a phenomenon we refer to as the microcatheter "first-pass effect." We found that blood flows slowly and temporarily through the vessel lumen at the site of occlusion when the angiographic microcatheter is advanced through the area of total occlusion and then retrieved on the proximal side of the occlusion. Thus, we conducted a retrospective study to evaluate whether the microcatheter first-pass effect observed during digital subtraction angiography can be used to differentiate ICAS from intracranial embolism.
METHODS

Study Patients
The study included 61 patients who were identified from our registry database of consecutive acute stroke patients treated with endovascular therapy between January 2015 and mid-October 2016. The selected patients met the following criteria: (1) the ischemic stroke resulted from occlusion of a large intracranial artery; (2) the time between symptom onset and admission was 8 h or less in the case of acute anterior circulation infarct or 24 h or less in the case of acute posterior circulation infarct, or the time between symptom onset and admission was beyond the 8 or 24 h, but endovascular therapy was to be performed for a moderate-to-large hypoperfusion area as depicted by multimodal MR imaging; (3) endovascular reperfusion therapy was performed, and successful recanalization was confirmed; (4) the age was above 18 yr; and (5) the prestroke modified Rankin Scale (mRS) score was 0 to 1.
Patients were excluded from the study if (1) the stroke was the result of dissection, moyamoya disease, or vasculitis; (2) the stroke was the result of tandem occlusion; or (3) the specific cause of the intracranial large artery occlusion was not determined.
Our access to patients' records for data collection and analysis of the data were approved by our local medical ethics committee. All patients provided informed consent for their clinical data to be used anonymously for research purposes.
Operational Definitions of ICAS and Embolic Occlusion
ICAS was differentiated from intracranial embolism collaboratively based on angiographic findings. ICAS was defined as a significant fixed focal stenosis at the site of occlusion evidenced by final angiography or during endovascular treatment. 11 In addition, the stenosis could be resolved by means of angioplasty or stent insertion. Significant stenosis was defined as (1) fixed stenosis ≥70% or (2) fixed stenosis ≥50% in addition to either angiographically evident impaired perfusion or evidence of re-occlusion following sufficient treatment with a stent retriever. The underlying disorder was classified as embolism based on the following: (1) there was no evidence of focal stenosis after clot retrieval; (2) an embolus was removed with a stent retriever; and (3) MR angiography (MRA) or computed tomography angiography (CTA) performed within 1 wk after the procedure showed the responsible artery to be patent without any stenosis.
Definition of the Microcatheter First-Pass Effect
A schematic diagram of the first-pass effect is shown in Figure 1 . When acute occlusion of a large intracranial artery is seen angiographically (Figure 1A ), the following procedure is performed before thrombectomy. A microcatheter and a microwire are navigated through the area of total occlusion to the distal patent artery ( Figure 1B) . The microcatheter is then retrieved on the proximal side of the thrombus. Angiography is performed with a guiding catheter or microcatheter to determine whether blood flows through the vessel at the site of occlusion. Such flow is recorded as the microcatheter first-pass effect ( Figure 1C ). If there is no such flow, absence of the first-pass effect is noted ( Figure 1D ). The firstpass effect is confirmed by 2 experienced neuro-interventionists who are present during the procedure.
Clinical and Radiological Assessment
We assessed neurological function of all study patients upon admission by means of the NIH Stroke Scale (NIHSS). We then assessed patients radiologically based on the Thrombolysis in Cerebral Infarction (TICI) scale, American Society of Interventional and Therapeutic Neuroradiology collateral grading (ACG) system, and the site of occlusion, as shown in Table 1 . Successful reperfusion was defined as a TICI grade of 2b or 3 after endovascular treatment, and good preprocedural collateral flow was defined as an ACG score ≥3. 20 High-resolution MR imaging was performed in some patients with ICAS who did not undergo stenting.
Patients' clinical characteristics, risk factors for arteriosclerosis, heart disease, preoperational intravenous thrombolysis, prior stroke, the hyperdense artery sign (HAS) on non-enhanced CT, the NIHSS score upon admission, and angiographic information were recorded. Two neurologists, blinded to the patient information and study protocol, independently studied all images retrospectively. Discrepancies between the reviewers were resolved by consensus.
Statistical Analysis
Differences in clinical characteristics, risk factors, and imaging features between patients in whom the microcatheter first-pass effect was observed and those in whom it was not observed were examined by bivariate analysis. Differences in clinical characteristics, risk factors, imaging features, and treatment strategies between patients with ICAS and those with intracranial embolism were also examined by bivariate analysis. Student's t-test or the Mann-Whitney U-test was applied to continuous variables, and the χ 2 test was applied to categorical variables. Measures of diagnostic performance, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of the microcatheter first-pass effect for the prediction of ICAS, were calculated. All statistical analyses were performed with IBM SPSS Statistics 22.0 (IBM Inc, Armonk, New York), and P ≤ .05 was considered significant.
RESULTS
Patients in Whom the Microcatheter First-Pass Effect was Observed vs Patients in Whom it was not Observed
The microcatheter first-pass effect was observed in 25 (41.0%) of the 61 study patients (Figure 2 ). Clinical characteristics are shown for patients in the first-pass effect group vs patients in the non-first-pass effect group in Table 2 . Patients in the first-pass effect group, in comparison to those in the non-first-pass effect group (Figure 3) , were more likely to be male (76.0% vs 47.2%, P = .025), more likely to have hypertension (80.0% vs 44.4%, P = .005), less likely to have atrial fibrillation and/or rheumatoid heart disease (12.0% vs 77.8%, P < .001), less likely to show the HAS on non-enhanced CT (21.6% vs 78.8%, P < .001), and less likely to have carotid T occlusion (0% vs 33.3%, P = .004).
The collateral flow was better in the microcatheter first-pass effect group than in the non-first-pass effect group (ACG ≥ 3, 50.0% vs 18.8%, P = .015).
Patients With ICAS vs Patients With Embolism
ICAS was diagnosed in 22 (36.1%) of the 61 patients. The clinical characteristics are shown for patients in the ICAS group vs patients in the non-ICAS (intracranial embolism) group in Table 3 . The ICAS patients were more likely to be male (81.8% vs 46.2%, P = .007), more likely to have hypertension (86.4% vs 43.6%, P = .001), more likely to have suffered a TIA (9.1% vs 0%, P = .040), less likely to have atrial fibrillation and/or rheumatoid heart disease (0% vs 79.5%, P < .001), less likely to show HAS on non-enhanced CT (22.2% vs 73.7%, P < .001), and less likely to have a carotid T occlusion (0% vs 30.8%, P = .010). The collateral flow was better in the ICAS group than in the non-ICAS group (ACG ≥ 3, 58.8% vs 18.9%, P = .003). Nineteen (86.4%) of the 22 ICAS patients required emergency angioplasty for successful recanalization (Table 4) . Nine patients with ICAS who did not receive a stent underwent high-resolution MR imaging. The stenosis in these cases was located in the proximal M1 segment (n = 4), the internal carotid terminus segment (n = 3), the distal M1 segment (n = 1), or the basilar artery (BA; n = 1). Stenosis of the responsible artery was observed in time-of-flight MRA, with irregular arteriosclerotic plaques of various thicknesses observed on volume isotropic turbo spin echo acquisition images in all 9 cases.
Diagnostic Performance of the Microcatheter First-Pass Effect
The microcatheter first-pass effect was positive in 20 of the 22 patients in the ICAS group but in only 5 patients in the non-ICAS group (90.9% vs 12.8%, respectively, P < .001). Sensitivity of the microcatheter first-pass effect for the detection of ICAS was 90.9%, specificity was 87.2%, PPV was 80.0%, NPV was 94.4%, and accuracy was 88.5%.
DISCUSSION
To the best of our knowledge, ours is the first study to show that clinicians can apply what we refer to as the microcatheter first-pass effect during endovascular intervention to differentiate ICAS from intracranial embolism. The microcatheter first-pass effect is the temporary slow blood flow seen at the site of total occlusion when a microcatheter is advanced through the affected artery and then retrieved on the proximal side of the occlusion. The phenomenon itself was first mentioned by Lee et al, 21 but VOLUME 0 | NUMBER 0 | 2018 | 5 they did not report that the interventionist can use it to differentiate ICAS from embolism. The microcatheter first-pass effect may result from the fact that the fresh clot burden is low in a stenotic intracranial artery; 3 the clot may easily break loose. When the microcatheter is advanced through a totally occluded artery, a portion of the fresh thrombus may be pushed into the distal patent segment, where it dissolves, and a portion may adhere to the vessel wall. Thus, a channel is established, and when the microcatheter is retrieved proximal to the occlusion site, transient slow flow can be seen angiographically.
FIGURE 2. Illustrative cases of the microcatheter first-pass effect. A 52-yr-old male smoker presented with right hemiparesis and aphasia. A, DSA revealed total occlusion of the terminal segment of the left ICA (black arrow). B, The microcatheter first-pass effect without focal stenosis was observed (black arrow indicates the distal end of the proximally retrieved the retrieved microcatheter). C, A 6.0-mm × 30-mm Solitaire stent (black arrow) was unsheathed at the occlusion site, and blood flowed through the site. D, Severe stenosis was seen after a single pass of the stent retriever (black arrow). E,
Our study showed significant association between the microcatheter first-pass effect and ICAS (90.9% in the ICAS group vs 12.8% in the non-ICAS group, P < .001) with high sensitivity (90.9%), high specificity (87.2%), high PPV (80%), high NPV (94.4%), and high accuracy (88.5%). Five other factors associated with ICAS differed between our patients in whom the first-pass effect was observed and those in whom it was not. The first was the presence of arteriosclerotic risk factors, hypertension in particular. Hypertension has been associated with ICAS. 11 The second was the prevalence of male sex, which corresponds to results of a study conducted by Lee et al 11 that showed an increased likelihood of ICAS among male patients. The third was absence of atrial fibrillation and/or a history of rheumatoid heart disease. Atrial fibrillation and rheumatic heart disease are conditions that put patients at risk for cardiac-embolic stroke. The fourth factor was the low occurrence of the HAS on nonenhanced CT. HAS is related to many factors such as the thrombus volume, stroke subtype, and components of the thrombus. 22, 23 Red thrombi are usually generated in diseased heart and are rich in red cells, whereas white thrombi are usually generated in atherosclerotic intracranial vessels and are rich in platelets. 22 The density of white thrombi is lower than that of red thrombi, 24, 25 so the HAS is predictive of cardioembolic stroke. 22 Finally, the most supportive point was that atherosclerosis plaque was observed on high-resolution MR images in 9 of the 22 ICAS cases, and first-pass effect was observed in all 9 of these cases.
We found no carotid T occlusion in either the microcatheter first-pass effect group or the ICAS group. It may be that the carotid T occlusion is related more to intracranial embolism and that the resulting thrombus burden is high. 26, 27 Thus, after the microcatheter is advanced through the site of occlusion and retrieved on the proximal side of the embolus, the artery is once again occluded by the high-burden thrombus, and the microcatheter first-pass effect is not observed.
Half (11/22, 50%) of the ICAS-related sites of occlusion were within the MCA, and the second most common sites were the intracranial ICA (6/22, 27.3%) and BA (5/22, 22.7%). Although the optimal treatment for underlying ICAS in patients presenting with hyperacute stroke remains unknown, the identification of underlying ICAS before endovascular therapy may help interventionists make appropriate therapeutic decisions. 19 Nineteen (86.4%) of our 22 study patients with ICAS required angioplasty for recanalization to be achieved, and this was done on an emergency basis. Therefore, we believe the neuro-interventionist can utilize this phenomenon to distinguish ICAS from embolism and then choose the most appropriate treatment. Platelets play an important role in rethrombosis in patients with ICAS, and antiplatelet therapy can be applied to inhibit re-occlusion. 12, 13 Once the microcatheter first-pass effect is observed, the probability of ICAS-related occlusion is high. We can administer tirofiban, which is a fast-acting, fast-deactivated, highly selective, non-peptide platelet membrane glycoprotein IIb/IIIa receptor inhibitor. 28 It is important to note that the clots in our ICAS patients were refractory to mechanical retrieval, necessitating emergency angioplasty. After diagnosing ICAS based on the firstpass effect, we can minimize the passage of a stent retriever, which can damage the arterial wall. 29 Additionally, limited passage of the stent retriever can minimize the procedure time, which factors into a good prognosis. 9 Our findings must be interpreted in light of the fact that they are based on single-center study. We also note that it might be difficult to differentiate underlying stenosis from residual emboli angiographically in patients who have undergone mechanical thrombectomy. CTA or MRA performed after the endovascular procedure in our patients with embolism showed that the responsible artery was patent without stenosis, whereas high-resolution MR performed in some of the patients with ICAS showed various degrees of stenosis and arthrosclerosis plaque burden in the responsible artery. These imaging studies verified that the differentiation between ICAS and embolism in our study patients was accurate.
CONCLUSION
In conclusion, we found the sensitivity of the microcatheter first-pass effect to be high for the identification of ICAS. Thus, the microcatheter first-pass effect can be used in determining an appropriate treatment strategy for patients with acute stroke.
Disclosure
